Quantitative Systematic Strategies’s Mersana Therapeutics MRSN Stock Holding History

Quantitative Systematic Strategies’s Portfolio MRSN Stock Details MRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-527	Closed	-$213K	–	584
2021 Q1	$213K	Sell	527 -160	-23%	-$77.6K	0.03%	550
2020 Q4	$457K	Sell	687 -397	-37%	-$221K	0.06%	406
2020 Q3	$505K	Buy	1,084 +261	+32%	+$132K	0.09%	321
2020 Q2	$481K	Sell	823 -941	-53%	-$321K	0.1%	317
2020 Q1	$257K	Buy	1,764 +916	+108%	+$160K	0.21%	171
2019 Q4	$121K	Buy	+848	New	+$62K	0.02%	518
2018 Q2	–	Sell	-687	Closed	-$271K	–	723
2018 Q1	$271K	Buy	+687	New	+$271K	0.06%	481

Other funds holding MRSN

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return